Sun Biomedical (ASX:SBN) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Sun Biomedical ROE % Adjusted to Book Value?

Sun Biomedical's ROE % for the quarter that ended in Dec. 2023 was -347.55%. Sun Biomedical's PB Ratio for the quarter that ended in Dec. 2023 was N/A. Sun Biomedical's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was N/A.

Sun Biomedical ROE % Adjusted to Book Value Historical Data

The historical data trend for Sun Biomedical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Biomedical ROE % Adjusted to Book Value Chart

Sun Biomedical Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

Sun Biomedical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Sun Biomedical's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Sun Biomedical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sun Biomedical's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sun Biomedical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Sun Biomedical's ROE % Adjusted to Book Value falls into.

Sun Biomedical ROE % Adjusted to Book Value Calculation

Sun Biomedical's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-135.42%	/	N/A
	=	N/A

Sun Biomedical's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-347.55%	/	N/A
	=	N/A

Sun Biomedical ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Sun Biomedical's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Biomedical (ASX:SBN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sun Biomedical Ltd (ASX:SBN) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

DXB:Australia

Address

425 Smith Street, Fitzroy, VIC, AUS, 3065

Website

https://www.dimerix.com

Dimerix Ltd is a biopharmaceutical company developing innovative new therapies in areas with unmet medical needs. The company is developing five product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for COVID-19 pneumonia patients in ICU; DMX-200 for respiratory complications in Covid-19 patients; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.

Sun Biomedical (ASX:SBN) Headlines

No Headlines